EGFR and lung carcinoma: Additionally, BRAF, known as a member of RAS signaling pathway genes, was reported to be involved in pro-mitogenic activity and acquired resistance to EGFR TKIs in lung cancer and colorectal cancer through activating the MAPK signaling axis [87, 88].